| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATRS | ANTARES PHARMA, INC. | Smith Karen L. | Director | May 24, 2022 | Option Exercise | $5.60 | 79,645 | 446,012 | 0 | May 26, 2022, 05:26 PM | |
| ATRS | ANTARES PHARMA, INC. | Smith Karen L. | Director | Jun 10, 2021 | Option Exercise | $4.42 | 25,452 | 112,498 | 79,645 | Jun 14, 2021, 06:27 PM | |
| XLRN | ACCELERON PHARMA INC | Smith Karen L. | Director | Apr 05, 2021 | Sale | $97.48 | 20,789 | 2,026,561 | 13,486 | Apr 05, 2021, 08:17 PM | |
| ATRS | ANTARES PHARMA, INC. | Smith Karen L. | Director | Jun 11, 2020 | Option Exercise | $2.73 | 30,220 | 82,501 | 54,193 | Jun 15, 2020, 09:15 PM | |
| ATRS | ANTARES PHARMA, INC. | Smith Karen L. | Director | Jun 13, 2019 | Option Exercise | $2.92 | 23,973 | 70,001 | 23,973 | Jun 14, 2019, 05:51 PM | |
| JAZZ | Jazz Pharmaceuticals plc | Smith Karen L. | EVP, R&D and CMO | Mar 05, 2018 | Option Exercise | $143.39 | 648 | 92,917 | 28,474 | Mar 07, 2018, 04:11 PM | |
| JAZZ | Jazz Pharmaceuticals plc | Smith Karen L. | EVP, R&D and CMO | Feb 26, 2018 | Option Exercise | $147.44 | 525 | 77,406 | 21,122 | Feb 28, 2018, 05:27 PM | |
| JAZZ | Jazz Pharmaceuticals plc | Smith Karen L. | EVP, R&D and CMO | May 11, 2017 | Option Exercise | $155.18 | 641 | 99,470 | 20,527 | May 12, 2017, 08:52 PM | |
| JAZZ | Jazz Pharmaceuticals plc | Smith Karen L. | Global Head of R&D and CMO | Feb 27, 2017 | Option Exercise | $136.97 | 571 | 78,210 | 13,668 | Mar 01, 2017, 05:16 PM | |
| JAZZ | Jazz Pharmaceuticals plc | Smith Karen L. | Global Head of R&D and CMO | Aug 12, 2016 | Buy | $137.10 | 608 | 83,356 | 14,182 | Aug 12, 2016, 04:36 PM | |
| JAZZ | Jazz Pharmaceuticals plc | Smith Karen L. | Global Head of R&D and CMO | Jul 13, 2016 | Buy | $143.63 | 580 | 83,305 | 13,574 | Jul 13, 2016, 08:09 PM | |
| JAZZ | Jazz Pharmaceuticals plc | Smith Karen L. | Global Head of R&D and CMO | Jun 13, 2016 | Buy | $149.61 | 557 | 83,335 | 12,994 | Jun 15, 2016, 05:17 PM | |
| JAZZ | Jazz Pharmaceuticals plc | Smith Karen L. | Global Head of R&D and CMO | May 11, 2016 | Option Exercise | $148.76 | 641 | 95,355 | 12,399 | May 12, 2016, 06:22 PM | |
| JAZZ | Jazz Pharmaceuticals plc | Smith Karen L. | Global Head of R&D and CMO | Apr 13, 2016 | Option Exercise | $147.34 | 103 | 15,176 | 13,040 | Apr 15, 2016, 04:54 PM |
Menu